How to Order Sucraid
Introduction
Please note: The services and contact information described below are available in the US only. For information on obtaining Sucraid® (sacrosidase) Oral Solution for patients located outside of the US, please see Outside USA.
As a specialty pharmaceutical product for a niche, orphan patient population, Sucraid® Oral Solution is not available through traditional retail pharmacies.
Instead QOL Medical, the maker of Sucraid® Oral Solution, uses an exclusive specialty pharmacy provider that ships therapy directly to the patient’s home or physician’s office. All shipments are refrigerated. This arrangement ensures that each patient receives his/her medication in a timely manner. This process applies to both the prescription product as well as the therapeutic response dose shipments.
Real Benefits of a Specialty Pharmacy Provider
Patient access to specialty, niche pharmaceuticals is often a complex process influenced by many factors including the extent of a patient's insurance coverage, co-pay requirements, and contracts between the patient's insurance provider and the drug benefit administrator or pharmacy benefits manager. Exclusive specialty pharmacy distribution channels are designed specifically to support such complexities. Beyond just arranging for direct shipment of Sucraid® Oral Solution to the patient’s home, the real benefit of using an exclusive specialty pharmacy provider is that it provides a full range of patient access and reimbursement support services. These services, which help healthcare providers, caregivers and/or patients access therapy, include:
- Insurance benefits verification
- Prior authorization resolution
- Defense of medical necessity (if needed)
- Co-pay determination and facilitation
- Co-pay assistance
- Patient assistance services for qualified patients (where allowable by federal and state law)
- Access to an on-call pharmacist 7 days a week, 24 hours a day
- Coordination of patient care with the physician’s office
Upon enrollment in the Sucraid® program, the physician’s office is contacted by an admissions healthcare coordinator who will explain the available services, research reimbursement, and coordinate shipment of the first order of Sucraid® with the patient. Each month thereafter, the patient is contacted by a patient care coordinator who will arrange additional shipments and monitor patient refills.
The specialty pharmacy provider model and supporting services facilitate patient access to Sucraid® Oral Solution to the fullest extent allowable by both federal and state laws.
Access to Sucraid® for New Patients – Prescription Use
Sucraid® (sacrosidase) Oral Solution is available by prescription only. If you are interested in obtaining a Sucraid® prescription, please contact your healthcare provider for more information.
It is important that licensed healthcare providers use the Sucraid® Patient Enrollment Form for new patients on therapy to ensure initial patient access and an uninterrupted supply of therapy as prescribed. Please complete the Sucraid® Patient Enrollment Form online, then print, sign (both patient and physician signature is required), and fax to 1-866-777-7097. You can also scan the completed form and email it to info@qolmed.com. This form provides all of the information required by the exclusive specialty pharmacy provider to arrange for patient access to Sucraid® Oral Solution.
- To prevent delays in delivery:
- Please be sure to complete the entire form, and include signatures from both the patient and the physician.
- The completed form should be faxed to 1-866-777-7097.
- If applicable, please provide alternate contact information (i.e., cell phone, email address, etc.) to ensure the exclusive specialty pharmacy provider can reach you to arrange delivery.
- If at any time there are changes regarding insurance, or if there is a change in physician, please notify the specialty pharmacy provider immediately.
Please click here to obtain the Sucraid® Patient Enrollment Form
Access to Sucraid® for Existing Patients – Prescription Use
Refill prescriptions for existing patients do not require completion of another
Sucraid® Patient Enrollment Form. Patients can obtain refill prescriptions for Sucraid® Oral Solution by calling 1-866-740-2743. Note: Sometimes your insurance provider may require another prescription to update the standing order.
How to Obtain a Therapeutic Response Dose
If the diagnosis of CSID is in doubt, it may be warranted to conduct a short therapeutic trial (e.g., approximately one week) with Sucraid® Oral Solution to assess response in a patient suspected of sucrase deficiency.1
Sucraid® Oral Solution is available for use as a therapeutic trial by licensed healthcare professionals by completing the Sucraid® Therapeutic Response Dose Enrollment Form and following the steps below:
- Complete the Sucraid® Therapeutic Response Dose Enrollment Form.
- Print and sign the completed form.
- Fax the form to 1-866-777-7097.
Upon completion of this enrollment form, the licensed healthcare professional will be shipped one bottle of Sucraid® Oral Solution (118 mL). A trained healthcare coordinator will follow up with the prescribing clinician to confirm receipt of shipment. Should the patient respond favorably to the therapeutic trial, the healthcare coordinator can also help facilitate the first prescription for starting therapy with Sucraid® Oral Solution.
Please click here to obtain the Sucraid® Therapeutic Response Dose Enrollment Form (pdf)
Reimbursement Support Services
QOL Medical has among the best patient access support services in the pharmaceutical industry. We will provide active case management support to assist patients and their caregivers in finding alternative coverage sources and accessing co-pay assistance.
Important Phone Numbers
To schedule your first delivery, obtain refill shipments, or for questions about your Sucraid® shipment, please call 1-866-740-2743. You may also use this number for questions about our Patient Assistance Programs or Co-Pay Support Programs.
Patient Enrollment Forms
For Prescription Use - Patient Enrollment Form (pdf)
Sucraid® Therapeutic Response Dose Enrollment Form (pdf)
More Information
Important Safety Information
For a complete discussion of indications, usage, contraindications, warnings, precautions, adverse reactions, and overdosage, please see full prescribing information attached. Do not use Sucraid® with patients known to be hypersensitive to yeast, yeast products, or glycerin (glycerol). Sucraid may contain papain which can cause allergic reactions in some patients. Adverse experiences with Sucraid in clinical trials were generally minor and were frequently associated with underlying disease. In clinical studies of up to 54 months duration, physicians treated a total of 52 patients with Sucraid. The adverse experiences and respective number of patients reporting each event were as follows: abdominal pain(4), vomiting(3), nausea(2), diarrhea(2), constipation(2), insomnia(1), headache(1), nervousness(1), and dehydration(1). Note: diarrhea and abdominal pain can be a part of the clinical presentation of the genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency. The effects of Sucraid have not been evaluated in patients with secondary (acquired) disaccharidase deficiency. In one clinical trial, one patient, a four year old boy who was being treated for asthma, experienced severe wheezing necessitating admission into the ICU. While reported reactions are extremely rare, care should be taken when administering initial doses of Sucraid to observe any signs of acute hypersensitivity reaction. Care should be taken to administer initial doses of Sucraid near a facility where acute hypersensitivity reactions can be adequately treated.1